selective COX-2 inhibitor called Prexige
December 2006
You'll soon see a new selective COX-2 inhibitor called Prexige.
Health Canada approved it ahead of the U.S. and most other countries. It's for acute and chronic osteoarthritis of the knee.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote